Skip to content

A study to compare effect of vacha pippali nasya and yashtimadhu madhu nasya in suryavarta( frontal sinusitis)

A comparative clinical study to evaluate the efficacy of yashtimadhu madhu avapeeda nasya with vacha pippali avapeeda nasya in suryavarta( frontal sinusitis)

Status
Active, not recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2022/06/043219
Enrollment
40
Registered
2022-06-13
Start date
Unknown
Completion date
Unknown
Last updated
2022-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: J011- Acute frontal sinusitis Health Condition 2: J321- Chronic frontal sinusitis

Interventions

None listed

Sponsors

Chandrasekharan P
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Patient within the age group of 16 to 60 years who will give their written consent 2. pt who will agree to follow protocol of study 3.subjects with symptoms of: a)shirashoola dinavruddha b) lalataruk c)akshiruk d)shankaruk e)spandanavat vedana f)tenderness over sinus area

Exclusion criteria

Exclusion criteria: 1)Subjects with complications of sinusitis. 2)Pregnant and lactating women. 3)Headaches with involvement of other intracranial pathology. 4)Subjects contraindicated for nasya. 5)Patients with other systemic illness.

Design outcomes

Primary

MeasureTime frame
The effect of treatment will be assessed based on detailed case proforma adopting methods of subjective parameters such as site, intensity and nature of pain. And also according to objective criteria like tenderness over sinus area and ESR. Pre and post interventional assessment will be doneTimepoint: The effect of treatment will be assessed before treatment( day 0), after treatment( day 7) and on day 14, 21 and 52

Secondary

MeasureTime frame
NILTimepoint: NIL

Countries

India

Contacts

Public ContactDr Apeksha D Rao

Alvas ayurveda medical college, affiliated with RGUHS

drapekshadrao@gmail.com7411360991

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026